Article
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
PloS one - 1 Jan 2008
Nosho Katsuhiko, Irahara Natsumi, Shima Kaori, Kure Shoko, Kirkner Gregory J, Schernhammer Eva S, Hazra Aditi, Hunter David J, Quackenbush John, Spiegelman Donna, Giovannucci Edward L, Fuchs Charles S, Ogino Shuji
Abstract excerpt
BACKGROUND: The CpG island methylator phenotype (CIMP) is a distinct phenotype associated with microsatellite instability (MSI) and BRAF mutation in colon cancer. Recent investigations have selected 5 promoters (CACNA1G, IGF2, NEUROG1, RUNX3 and SOCS1) as surrogate markers for CIMP-high. However, no study has comprehensively evaluated an expanded set of methylation markers (including these 5 markers) using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
